The Paradise ultrasound renal denervation system got backing from the FDA's Circulatory System Devices Panel as a possible treatment for hypertension, as manufacturer ReCor continues to hope for ...

Credit: Recor Medical. The approval was based on data from the RADIANCE II trial which included patient with mild to moderate hypertension who were adequately controlled with medications. The Food and ...

Credit: Medtronic. The Simplicity Spyral RDN system is designed to lower BP by delivering radiofrequency energy through the wall of the renal artery to denervate the kidney from sympathetic nerve ...

In the past two years we have observed 4 patients with manifestations of deranged function of the central nervous system in whom hyponatremia appeared to be related to an abnormal secretion of ...

Advisors on the US Food and Drug Administration’s Circulatory System Devices Panel voted today in support of the premarket approval (PMA) application for the Paradise Ultrasound Renal Denervation ...

A version of this article was published by HCPLive®. This version has been lightly edited. The FDA has approved the Paradise Ultrasound Renal Denervation (uRDN) system for the treatment of ...

The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the ...

A real-world study finds favorable stone-free rates after use of SURE with the CVAC® system to treat kidney stone burdens typically less than 2 cm. Despite its relatively novel status, steerable ...

Cancer Genetic Services in a Low- to Middle-Income Country: Cross-Sectional Survey Assessing Willingness to Undergo and Pay for Germline Genetic Testing We included patients with mRCC enrolled in the ...